Immatics N.V. SEC filings IMTX
Immatics N.V. has 243 filings in SEC EDGAR's recent list, going back to Apr 16, 2020. Its latest annual report, Form 20-F, was filed on Mar 5, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 26, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Aug 27, 2026 | Aug 26, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 27, 2026 | — |
| 4 | Insider transaction | Aug 18, 2026 | Aug 14, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 3 | Initial insider ownership | Jul 29, 2026 | Jul 20, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 17, 2026 | Mar 17, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 12, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 12, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 2, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 7, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 11, 2025 | — |
| SC 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 8, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Oct 17, 2024 | — |
| SC 13D | Ownership over 5% (active) | Jun 6, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jun 6, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 8, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 7, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 7, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Aug 16, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 10, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Feb 7, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2022 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 11, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Feb 16, 2021 | — |
| SC 13G | Ownership over 5% (passive) | Feb 12, 2021 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Aug 10, 2020 | — |
Showing 74 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- IMTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Netherlands
- Headquarters
- Tubingen, Germany
- SEC filer status
- Accelerated filer
- SEC CIK
- 1809196
- Former names
- Immatics B.V. (until Jul 8, 2020)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.